edatrexate has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruzzese, JL; Ajani, JA; Belt, RJ; Bready, B; Dubovsky, DW; Mangold, C; Moore, DF; Pazdur, R; Wade, JL; Winn, RJ | 1 |
| Casper, ES; Johnson, B; Kelsen, DP; Schwartz, GK | 1 |
2 trial(s) available for edatrexate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate | 1994 |
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aminopterin; Antineoplastic Agents; Bile Duct Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1992 |